The use and safety profile of non-steroidal anti- inflammatory drugs among Turkish patients with osteoarthritis Türkiye'deki osteoartrit hastalar› aras›nda non-steroid antiinflamatuvar ilaçlar›n kullan›m› ve güvenlilik profili

作者: Hürriyet Yilmaz , Selim Gürel

DOI:

关键词:

摘要:

参考文章(15)
W. H. Ettinger, M. A. Davis, J. M. Neuhaus, K. P. Mallon, Knee osteoarthritis and physical functioning: evidence from the NHANES I Epidemiologic Followup Study. The Journal of Rheumatology. ,vol. 18, pp. 591- 598 ,(1991)
Gary A. Green, Understanding NSAIDs: from aspirin to COX-2. Clinical Cornerstone. ,vol. 3, pp. 50- 59 ,(2001) , 10.1016/S1098-3597(01)90069-9
William G. Bensen, Justus J. Fiechtner, James I. McMillen, William W. Zhao, Shawn S. Yu, Emmett M. Woods, Richard C. Hubbard, Peter C. Isakson, Kenneth M. Verburg, G. Steven Geis, Treatment of Osteoarthritis With Celecoxib, a Cyclooxygenase-2 Inhibitor: A Randomized Controlled Trial Mayo Clinic Proceedings. ,vol. 74, pp. 1095- 1105 ,(1999) , 10.4065/74.11.1095
P. I. Pillans, J. M. Radford, P. G. Landsberg, Evaluation of cyclooxygenase 2 inhibitor use in patients admitted to a large teaching hospital. Internal Medicine Journal. ,vol. 33, pp. 225- 228 ,(2003) , 10.1046/J.1445-5994.2003.00392.X
David L. B. Schwappach, Christian M. Koeck, Selective COX-2 inhibitors: a health economic perspective. Wiener Medizinische Wochenschrift. ,vol. 153, pp. 116- 122 ,(2003) , 10.1046/J.1563-258X.2003.03006.X
Michael J Langman, Dennis M Jensen, Douglas J Watson, Sean E Harper, Peng-Liang Zhao, Hui Quan, James A Bolognese, Thomas J Simon, Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. JAMA. ,vol. 282, pp. 1929- 1933 ,(1999) , 10.1001/JAMA.282.20.1929
AJ Kivitz, RW Moskowitz, E Woods, RC Hubbard, KM Verburg, JB Lefkowith, GS Geis, Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip. Journal of International Medical Research. ,vol. 29, pp. 467- 479 ,(2001) , 10.1177/147323000102900602
O. Sangha, Epidemiology of rheumatic diseases Rheumatology. ,vol. 39, pp. 3- 12 ,(2000) , 10.1093/RHEUMATOLOGY/39.SUPPL_2.3
C. Hawkey, A. Kahan, K. Steinbruck, C. Alegre, E. Baumelou, B. Begaud, J. Dequeker, H. Isomaki, G. Littlejohn, J. Mau, S. Papazoglou, Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. International MELISSA Study Group. Meloxicam Large-scale International Study Safety Assessment. Rheumatology. ,vol. 37, pp. 937- 945 ,(1998) , 10.1093/RHEUMATOLOGY/37.9.937
David T. Felson, Allan Naimark, Jennifer Anderson, Lewis Kazis, William Castelli, Robert F. Meenan, The prevalence of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis & Rheumatism. ,vol. 30, pp. 914- 918 ,(1987) , 10.1002/ART.1780300811